|
| Name of the Study |
DOI |
First Author |
|
|
| |
|
|
|
| Candida auris outbreak in a COVID-19 specialty care unit—Florida, July–August 2020 |
10.15585/mmwr.mm7002e3 |
Prestel, C. |
|
| Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient |
10.1097/MD.0000000000025173 |
Anggraini Permata Sari |
|
| Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic |
10.1111/myc.13225 |
Nucci, M. |
|
| Epidemiology and Mycology of Candidaemia in non‐oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non‐COVID‐19 and COVID‐19 cases |
10.1111/myc.13258 |
Macauley, P. |
|
| Post COVID-19 opportunistic candida retinitis: A case report |
10.4103/ijo.IJO_3047_20 |
Bhagali, R., |
|
| Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation |
10.1093/ajcp/aqaa264 |
Aesif, S.W. |
|
| Mixed mold infection with Aspergillus fumigatusand Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient |
10.1016/j.idnow.2021.01.010 |
A.-P. Bellanger |
|
| Rhinocerebral Mucormycosis and COVID-19 Pneumonia |
10.14740/jmc3637 |
Alekseyev, K. |
|
| Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report |
10.5946/ce.2020.180 |
do Monte Junior ES |
|
| Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature |
10.1007/s11046-021-00528-2 |
Garg, D |
|
| Pulmonary aspergillosis and mucormycosis in a patient with COVID-19 |
10.1016/j.mmcr.2021.03.006 |
Johnson, A.K. |
|
| A fatal case of Rhizopus azygosporus pneumonia following COVID-19 |
10.3390/jof7030174 |
Kanwar, A. |
|
| Fulminant mucormycosis complicating coronavirus disease 2019 (COVID‐19) |
10.1002/alr.22785 |
Karimi‐Galougahi, M. |
|
| Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient–case report and review of literature |
10.1016/j.mycmed.2021.101125 |
Khatri, A |
|
| Sino-orbital mucormycosis in a COVID-19 patient: A case report |
10.1016/j.ijscr.2021.105957 |
Maini, A. |
|
| A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection |
10.1007/s15010-020-01561-x |
Pasero, D. |
|
| Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia |
10.1016/j.radcr.2020.09.026 |
Placik, D.A. |
|
| COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? |
10.1136/bcr-2021-241663 |
Revannavar, S.M. |
|
| |
10.1007/s12070-021-02574-0 |
Saldanha, M. |
|
| Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. |
10.1177/11206721211009450 |
Veisi, A. |
|
| A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19 |
10.7759/cureus.13163 |
Waizel-Haiat, S |
|
| Mucormycosis with orbital compartment syndrome in a patient with COVID-19 |
10.1016/j.ajem.2020.09.032 |
Werthman-Ehrenreich, A. |
|
| The double-edged sword of systemic corticosteroid therapyin viral pneumonia: A case report and comparative reviewof influenza-associated mucormycosis versus COVID-19associated mucormycosis |
10.1111/myc.13256 |
Kazem Ahmadikia |
|
